CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $969,122 | -17.7% | 21,351 | +1.7% | 0.01% | -20.0% |
| Q2 2023 | $1,178,154 | +20.9% | 20,986 | -2.6% | 0.01% | +11.1% |
| Q1 2023 | $974,752 | +14.7% | 21,551 | +3.1% | 0.01% | +12.5% |
| Q4 2022 | $850,032 | -35.0% | 20,911 | +4.6% | 0.01% | -42.9% |
| Q3 2022 | $1,307,000 | +8.2% | 19,996 | +0.6% | 0.01% | +16.7% |
| Q2 2022 | $1,208,000 | +16.3% | 19,876 | +20.1% | 0.01% | +50.0% |
| Q1 2022 | $1,039,000 | -16.4% | 16,549 | +0.9% | 0.01% | -11.1% |
| Q4 2021 | $1,243,000 | -32.7% | 16,407 | -0.6% | 0.01% | -40.0% |
| Q3 2021 | $1,848,000 | -30.4% | 16,511 | +0.7% | 0.02% | -31.8% |
| Q2 2021 | $2,655,000 | +26.6% | 16,403 | -4.7% | 0.02% | +22.2% |
| Q1 2021 | $2,097,000 | -10.3% | 17,213 | +12.8% | 0.02% | -14.3% |
| Q4 2020 | $2,337,000 | +80.6% | 15,262 | -1.4% | 0.02% | +61.5% |
| Q3 2020 | $1,294,000 | +97.3% | 15,476 | +73.4% | 0.01% | +44.4% |
| Q2 2020 | $656,000 | +119.4% | 8,927 | +26.6% | 0.01% | +80.0% |
| Q1 2020 | $299,000 | – | 7,052 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |